Tetrahydrocurcumin Add-On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury.

Pharmacol Res Perspect · 2023 · PMC10041385 · PMID 36971089

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Systolic BP was significantly lower in the THC + PPC + losartan group compared to untreated CKD rats; there was a trend for lower BP in the losartan group which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.